47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme Sunday, 14 March 2021 CME Symposium 08:30 - 10:00 Auditorium 1 IS1, GMMG Symposium Chairs: Hartmut Goldschmidt (Germany) Christof Scheid (Germany) Role of allo-TPX in multiple myeloma 08:30 - 08:43 Nicolaus Kröger (Germany) Importance of achieving a Minimal Residual Disease Negativity in 08:43 - 08:56 multiple myeloma Stefanie Huhn (Germany) Role of induction therapy in treatment of multiple myeloma 08:56 - 09:09 Hans Salwender (Germany) Therapy and prognosis of high-risk multiple myeloma 09:09 - 09:22 Katja Weisel (Germany) Therapeutic developments for refractory multiple myeloma 09:22 - 09:35 Marc Raab (Germany) Cellular therapy in multiple myeloma 09:35 - 09:48 Christof Scheid (Germany) Q&A 09:48 - 10:00 Non-Profit Symposium 08:30 - 10:00 Auditorium 2 IS2, Latest developments in hematopoietic cell transplantation - Sorbonne University (ATERHIT) non-profit symposium Chairs: Arnon Nagler (Israel) Bipin Savani (United States) Haplo transplant for AML 08:30 - 08:48 Arnon Nagler (Israel) Haplo transplant for the elderly 08:48 - 09:06 Didier Blaise (France) Monoclonal antibodies in ALL 09:06 - 09:24 Eolia Brissot (France) Monoclonal antibodies in Hodgkin lymphoma 09:24 - 09:42 Ali Bazarbachi (Lebanon) Page 1 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme Allogeneic transplantation after CAR T-cell therapy 09:42 - 10:00 Bipin Savani (United States) Non-Profit Symposium 08:30 - 10:00 Auditorium 3 IS3, Multiple myeloma in 2021: the IFM global perspective - IFM non-profit symposium Chairs: Mohamad Mohty (France) Jean-Luc Harousseau (France) What's new for induction prior to ASCT? 08:30 - 08:52 Philippe Moreau (France) What's new in the elderly setting? 08:52 - 09:14 Thierry Facon (France) Monoclonal antibodies for relapse after ASCT 09:14 - 09:36 Mohamad Mohty (France) Requirements for functional cure in myeloma 09:36 - 09:58 Jean-Luc Harousseau (France) Non-Profit Symposium 08:30 - 10:00 Auditorium 4 IS4, Dilemma in allogeneic hematopoietic transplantation for myelofibrosis - SFGM- TC non-profit symposium Chairs: Jacques Olivier Bay (France) Thierry Guillaume (France) Impact of HSCT in ruxolitinib area 08:30 - 08:50 Marie Robin (France) Transplantation with an alternative donor: Results and perspectives 08:50 - 09:10 Nicolaus Kröger (Germany) Liver specificities in myelofibrosis and impact on transplantation 09:10 - 09:30 procedure Audrey Payance (France) Q&A 09:30 - 10:00 Industrial Theatre 08:30 - 18:45 Industry Theatre IT1, Kite-Gilead Industry Theatre session Page 2 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme Industrial Theatre 08:30 - 18:45 Industry Theatre IT2, BMS Industry Theatre session Industrial Theatre 08:30 - 18:45 Industry Theatre IT3, Novartis Industry Theatre session Industrial Theatre 08:30 - 18:45 Industry Theatre IT4, Fresenius Kabi Industry Theatre session Nurses Group 08:30 - 18:45 On-Demand Library NG13, Nurses Education Day 1: Care of the vulnerable immunocompromised patients in critical care setting SARS-CoV-2 vaccines overview Almudena Ramírez (Spain) Disaster management plan: JACIE recommendations COVID-19: The EBMT recommendations for management of HCT patients and donors Per Ljungman (Sweden) Nurses Group 08:30 - 18:45 On-Demand Library NG14, Nurses Education Day 2: Care of the vulnerable immunocompromised patients in critical care setting Patient's experience Ruth Tweedie (Spain) Miguel Trapero Veledo (Spain) Psychologist's point of view Nurse's perspective Page 3 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme Nurses Group 08:30 - 18:45 On-Demand Library NG15, Nurses Education Day 3: Care of the vulnerable immunocompromised patients in critical care setting Managing virtual conversations Lloyd Allen (United Kingdom) Nurse perspective: Virtual long term follow up for BMT patients Michelle Kenyon (United Kingdom) Back to the future: Emphasizing our new practices Ibrahim Yakoub-Agha (France) Lab Technicians Day 08:30 - 18:45 On-Demand Library LT1, Lab Technicians Day: Specialized cell processing Bone marrow processing: Techniques and results Boris Calmels (France) Technical aspects and performance TCRab/CD19 depletion Kasper Westinga (Netherlands) Donor selection and GMP-compliant manufacturing of virus-specific T- cells Britta Eiz-Vesper (Germany) Lab Technicians Day 08:30 - 18:45 On-Demand Library LT2, Lab Technicians Day: Cell product testing, validation and characterization Quality control assessment of ATMP phenotype and functionality using flow cytometry Willemijn Hobo (Netherlands) Flow cytometry-based CD34 enumeration Harry Dolstra (Netherlands) Flow cytometric in-process and quality control for CAR T cell manufacturing Ulrike Köhl (Germany) Educational 08:30 - 18:45 On-Demand Library E8, New challenges in infectious complications Page 4 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme T-cell therapy for infections in SCT patients: An experimental treatment or a real choice for the practice? Patrizia Comoli (Italy) Infectious complications with new drugs in Hematology Georg Maschmeyer (Germany) The blood virome of HSCT Recipients: Much more than viremia by CMV, EBV, HH6V and adenovirus Marie-Celine Zanella (Switzerland) Educational 08:30 - 18:45 On-Demand Library E9, Allogeneic HSCT in MDS and MPN Definition of graft failure/relapse after allo-HCT in myelofibrosis Donal McLornan (United Kingdom) Allogeneic HSCT in patients with therapy-related MDS/AML Marie Robin (France) The role of maintenance therapy after allogeneic HSCT in MDS Francesco Onida (Italy) Educational 08:30 - 18:45 On-Demand Library E10, HSCT in paediatric non-malignant indications Haplo-identical SCT in hemoglobinopathy: Taking pole position? Josu de la Fuente (United Kingdom) Mismatched family donors in inherited immune disorders: A new perspective Mary A. Slatter (United Kingdom) HSCT for inherited bone marrow failure syndromes Cristina Díaz de Heredia (Spain) Cord blood HSCT for non-malignant diseases in children Vanderson Rocha (Brazil) Educational 08:30 - 18:45 On-Demand Library E11, Management of early complications in an ambulatory/outpatient setting Early infectious complications Jan Styczynski (Poland) Page 5 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme Non-infective complications: GVHD and organ toxicity Gerhard Hildebrandt (United States) The Hospital Clínic experience Francesc Fernández-Avilés (Spain) Educational 08:30 - 18:45 On-Demand Library E12, Steroid-resistant/refractory GVHD GVHD - what’s in a name? Helene Schoemans (Belgium) Treatment of SR/R acute GVHD Olaf Penack (Germany) Treatment of SR/R chronic GVHD Zinaida Peric (Croatia) New technologies in the approach to GVHD Amin Turki (Germany) Educational 08:30 - 18:45 On-Demand Library E13, Allogeneic transplantation from alternative donors Haploidentical vs unrelated in AML Didier Blaise (France) Haploidentical vs unrelated in ALL Arnon Nagler (Israel) Haploidentical vs cord Blood in acute leukaemia Frederic Baron (Belgium) Working Party Session 08:30 - 18:45 On-Demand Library ALWP, Acute Leukaemia Working Party Session Introduction Mohamad Mohty (France) CAR-T cells in adult ALL Arnon Nagler (Israel) Transplant in refractory AML: Comparison of the different FLAMSA approaches Mohamad Mohty (France) Page 6 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme MRD in AML: Where do we stand? Ali Bazarbachi (Lebanon) PTCy GVHD prophylaxis-quo vadis? Leonido Luznic (United States) Working Party Session 08:30 - 18:45 On-Demand Library SAAWP, Severe Aplastic Anaemia Working Party Session Introduction Régis Peffault de Latour (France) Registry Report Antonio Risitano (Italy) RACE – clinical update Antonio Risitano (Italy) RACE – what we learn on the biology of SAA? Austin Kulakaseraraj (United Kingdom) Androgens in AA: Myth or reality in 2021? Simona Pagliuca (United States) GVHD and relapse free survival (GRFS) after HSCT for AA Raynier Devillier (France) Working Party Session 08:30 - 18:45 On-Demand Library ADWP, Autoimmune Diseases Working Party Session Welcome and Update from the EBMT registry Raffaella Greco (Italy) Introducing the session and speakers Tobias Alexander (Germany) HSCT for multiple sclerosis: Future directions in patient selection and conditioning regimen Riccardo Saccardi (Italy) HSCT for systemic sclerosis: Future directions in patient selection and conditioning regimen Dominique Farge (France) HSCT for Crohn’s disease: future directions in patient selection, mobilization and conditioning regimen Elena Ricart (Spain) Page 7 / 103 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), 14 - 17 March 2021 Scientific Programme HSCT for autoimmune diseases: Current aspects on early and late complications Majid Kazmi (United Kingdom) HSCT for autoimmune diseases: Conditioning regimen and outcomes from the Russian experience Denis Fedorenko (Russian Federation) Closing remarks Tobias Alexander (Germany) Working Party Session 08:30 - 18:45 On-Demand Library CMWP, Chronic Malignancies